CRDF

Insider Buying Week 12-13-24 When does the Hammer Come Down?

by

I’d like to say I saw something last week that was sexy and showed a lot of potential.   Maybe I’m missing it and its staring right at you but you have to rely on more than insider buying to validate your purchase. I said that to myself and despite that I bought the management line that Dave and Busters didn’t need revenue growth but could rely on more efficient operations. Then the CEO quits two months later for a better job? Class action attorneys, you can include me on your mailer. Market momentum stalled last week. The 10-year Treasury sold … Read more

The Bold, the Inexplicable and the Good Soldiers- Insider Buying Week 9-17-21

by

For trade, details click on this link to the trades.  There were quite a few buys last week and it took me longer than usual to update it. Also, I will provide a brief recap of the conversation I had with the Chief Medical Officer, Alexander A. Zukiwski at Casi Pharmaceuticals. Casi is a U.S. NASDAQ-listed biotech selling exclusively to the increasingly affluent Chinese middle class.  CASI is a penny stock that will turn into $dollars if things pan out the way I think. They have one approved revenue-producing product with an exciting pipeline. There is a high probability they … Read more

Insider Buying Picks Up- Week Ending 5-15-20

by

Insider buying picked up this week across several depressed sectors like insurance,  small regional banks,  gaming, furniture, REITS, building products, restaurants and retailers, automotive and motorcycle and utility stocks. The buy of the week is property and casualty California auto insurer, Mercury General MCY.  Chairman of the Board George Joseph continued accumulating stock with $15 million of stock purchases at an average price of $35.95. MCY is down from it’s high this year of $52.  MCY yields 6.65%. People are driving less and insurance claim losses are down  as a result of that. Offsetting this, reinvestment rates on bond portfolios … Read more